SCHEMBL197287

SCHEMBL197287

CN(C)Cc1ccc(Cl)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.64
TAAR1 Q96RJ0 2/20 0.57
ALDH1A1 P00352 2/20 0.56
TSHR P16473 2/20 0.56
PYCR1 P32322 1/20 0.55
LSS P48449 3/20 0.54
HTT P42858 1/20 0.53
RAB9A P51151 1/20 0.53
AOC3 Q16853 1/20 0.50
POLB P06746 1/20 0.50
CYP1A2 P05177 1/20 0.46
CHRM2 P08172 1/20 0.46
ADRA2A P08913 1/20 0.46
CYP2D6 P10635 1/20 0.46
CHRM1 P11229 1/20 0.46
DRD1 P21728 1/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A4 P31645 1/20 0.46
CYP2C19 P33261 1/20 0.46
ADRA1A P35348 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27816032 0.97 HRH3 (0.61) HRH3TAAR1ALDH1A1TSHRPYCR1
Methylene Chloride SCHEMBL6061380 0.95 HRH3 (0.58) HRH3TAAR1ALDH1A1TSHRPYCR1
Dibromomethane SCHEMBL6061514 0.93 HRH3 (0.56) HRH3TAAR1ALDH1A1TSHRPYCR1
SCHEMBL2056269 0.93 HRH3 (0.77) HRH3TAAR1ALDH1A1TSHRPYCR1
SCHEMBL10612102 0.87 HRH3 (0.50) HRH3TAAR1ALDH1A1TSHRPYCR1
SCHEMBL7860102 0.87 LSS (0.58) HRH3TAAR1ALDH1A1TSHRPYCR1
SCHEMBL659509 0.86 HRH3 (0.82) HRH3TAAR1ALDH1A1TSHRAOC3
Octane SCHEMBL10612108 0.85 KCNH2 (0.51) HRH3TAAR1ALDH1A1TSHRPYCR1
SCHEMBL18532755 0.84 PYCR1 (0.67) HRH3ALDH1A1TSHRPYCR1LSS
SCHEMBL19389734 0.84 LSS (0.58) HRH3TAAR1ALDH1A1LSSHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3041819-B1 IMPROVED PROCESS FOR THE REDUCTIVE AMINATION OF SUBSTRATES CONTAINING A SELECTED HALOGEN TAMINCO BVBA (BE) 2020-05-13 EP claimed
US-10252979-B2 Process for the reductive amination and selective hydrogenation of substrates containing a selected halogen TAMINCO BVBA (BE) 2019-04-09 US claimed
US-20170342019-A1 PROCESS FOR THE REDUCTIVE AMINATION AND SELECTIVE HYDROGENATION OF SUBSTRATES CONTAINING A SELECTED HALOGEN TAMINCO BVBA (BE) 2017-11-30 US claimed
CN-106034401-A Improved process for reductive amination and selective hydrogenation of substrates containing selected halogens 塔明克公司 2016-10-19 CN claimed
US-20160207874-A1 IMPROVED PROCESS FOR THE REDUCTIVE AMINATION AND SELECTIVE HYDROGENATION OF SUBSTRATES CONTAINING A SELECTED HALOGEN TAMINCO BVBA (BE) 2016-07-21 US claimed
EP-3041819-A1 IMPROVED PROCESS FOR THE REDUCTIVE AMINATION AND SELECTIVE HYDROGENATION OF SUBSTRATES CONTAINING A SELECTED HALOGEN Taminco bvba (BE) 2016-07-13 EP claimed
WO-2015032653-A1 IMPROVED PROCESS FOR THE REDUCTIVE AMINATION AND SELECTIVE HYDROGENATION OF SUBSTRATES CONTAINING A SELECTED HALOGEN TAMINCO (BE) 2015-03-12 WO claimed
US-20080200454-A1 CARBON-LINKED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S SUNESIS PHARMACEUTICALS, INC. 2008-08-21 US claimed
WO-2008100618-A2 CARBON-LINKED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S SUNESIS PHARMACEUTICALS, INC. (US) 2008-08-21 WO claimed
CN-117531520-A Catalyst and preparation method and application thereof 厦门大学 2024-02-09 CN disclosed
WO-2024027109-A1 CATALYST, PREPARATION METHOD THEREFOR AND USE THEREOF XIAMEN UNIVERSITY (CN) 2024-02-08 WO disclosed
EP-3374344-B1 IMPROVED PROCESS FOR THE REDUCTIVE AMINATION OF HALOGEN-CONTAINING SUBSTRATES TAMINCO BV (BE) 2023-10-04 EP disclosed
CN-114436851-B Preparation method of N, N-dimethylbenzylamine and derivatives thereof 常州大学 2023-08-22 CN disclosed
US-11718614-B2 Compounds and methods for treatment of hedgehog pathway associated conditions SUZHOU MEDNES PHARMA TECH CO., LTD. (CN) 2023-08-08 US disclosed
US-4099012-A ANTIANXIETY, ANTIDEPRESSANT CIBA-GEIGY CORPORATION (US) 1978-07-04 US disclosed
US-4028381-A ANTIANXIETY AND ANTIDEPRESSANT AGENTS CIBA-GEIGY CORPORATION (US) 1977-06-07 US disclosed
US-4022801-A ANTIANXIETY AND ANTIDEPRESSANTS CIBA-GEIGY CORPORATION (US) 1977-05-10 US disclosed
US-4022800-A ANTIANXIETY AND ANTIDEPRESSANTS CIBA-GEIGY CORPORATION (US) 1977-05-10 US disclosed
US-3947585-A ANTIANXIETY, ANTIDEPRESSANTS CIBA-GEIGY CORPORATION (US) 1976-03-30 US disclosed
US-3939271-A Antidepressive and antianxiety composition comprising 2-pyrazolyl-benzophenones CIBA-GEIGY CORPORATION (US) 1976-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718614-B2 Compounds and methods for treatment of hedgehog pathway associated conditions SHH, GLI1, SMO HRH3 1229/4885TAAR1 3479/4885ALDH1A1 786/4885
US-20080200454-A1 CARBON-LINKED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S CTSS, CTSK, CTSZ HRH3 354/4885TAAR1 3251/4885ALDH1A1 4404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.